PUBLISHER: The Business Research Company | PRODUCT CODE: 1945229
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945229
Gastrointestinal (GI) bleeding serves as a symptom of an underlying illness where the gastrointestinal system experiences bleeding. The bleeding can manifest in various parts of the gastrointestinal tract, encompassing the large intestine, anus, esophagus, small intestine, rectum, and stomach.
In the gastrointestinal bleeding treatment devices market, the primary types of products include endoscopic mechanical devices, endoscopic thermal devices, and others. Endoscopic mechanical devices play a crucial role in managing GI arterial bleeding and comprise hemostatic clips, also known as through-the-scope (TTS) clips, endoscopic detachable snare ligation (EDSL) devices, endoscopic suturing, and over-the-scope clips (OTSC). These devices are subject to review for their technological applications and clinical utility. The segmentation of the gastrointestinal bleeding treatment devices market includes divisions based on the GI tract, distinguishing between the lower GI tract and upper GI tract. Additionally, these devices find application in various healthcare settings, such as hospitals or clinics, ambulatory surgical centers, and other medical facilities.
Tariffs are influencing the gastrointestinal bleeding treatment devices market by increasing costs of imported endoscopic components, thermal generators, imaging accessories, and precision instruments. Hospitals and ambulatory centers in North America and Europe are most affected due to dependence on imported endoscopy systems, while Asia-Pacific faces higher export-related costs. These tariffs are increasing device procurement expenses and affecting upgrade cycles. However, they are also encouraging localized device assembly, regional manufacturing partnerships, and development of cost-efficient hemostatic technologies.
The gastrointestinal bleeding treatment devices market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal bleeding treatment devices market statistics, including gastrointestinal bleeding treatment devices industry global market size, regional shares, competitors with a gastrointestinal bleeding treatment devices market share, detailed gastrointestinal bleeding treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal bleeding treatment devices industry. This gastrointestinal bleeding treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gastrointestinal bleeding treatment devices market size has grown strongly in recent years. It will grow from $0.92 billion in 2025 to $1 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing incidence of gastrointestinal disorders, rising prevalence of peptic ulcer disease, expansion of endoscopic diagnostic procedures, growing hospital-based gi interventions, availability of advanced endoscopy equipment.
The gastrointestinal bleeding treatment devices market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of next-generation endoscopic devices, rising demand for outpatient gi procedures, growing focus on early bleeding detection, expansion of ambulatory surgical centers, increasing investments in advanced gi care technologies. Major trends in the forecast period include increasing adoption of advanced endoscopic hemostasis devices, rising use of minimally invasive gi bleeding treatments, growing demand for precision thermal ablation tools, expansion of mechanical hemostatic solutions, enhanced focus on rapid bleeding control technologies.
The rising prevalence of gastrointestinal disorders is anticipated to enhance the market's attractiveness. Gastrointestinal diseases may arise from factors such as a low-fiber diet, stress, insufficient water intake, high consumption of dairy products, a sedentary lifestyle, aging, and genetic predispositions. For example, in October 2024, the National Library of Medicine, a US-based national library, reported that in 2023, there were 825 cases per 100,000 Canadians diagnosed with inflammatory bowel disease (IBD), affecting over 320,000 individuals. Projections suggest that this number could increase to 1.1% of the population, approximately 470,000 Canadians, by 2035. Thus, the growing prevalence of disorders related to the gastrointestinal tract is propelling market growth.
Leading companies in the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the gastrointestinal (GI) tract. Hemospray is a hemostatic powder designed to manage and control active bleeding in the GI tract. For instance, in January 2024, AIG Hospitals, an India-based medical institution, introduced Hemospray, marking a significant advancement in controlling GI bleeding. This hemostatic agent is specifically designed for use in endoscopic procedures to manage acute gastrointestinal (GI) bleeding. Hemospray is recognized for its ease of use, safety profile, and effectiveness in controlling a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.
In June 2023, Merck, a US-based global pharmaceutical company, acquired Prometheus Biosciences, Inc. for $10.8 billion. This acquisition greatly strengthens Merck's position in the immunology sector, an area in which the company had previously been less active. Prometheus Biosciences, Inc. is a US-based biotechnology firm that specializes in the discovery, development, and commercialization of innovative precision therapies and diagnostics for patients with gastrointestinal (GI) and immune-mediated diseases.
Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the gastrointestinal bleeding treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The gastrointestinal bleeding treatment devices market consists of sales of thermal therapy, multipolar electrocoagulation probe, heater probe, hemostatic foreceps, and argon plasma coagulation. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gastrointestinal Bleeding Treatment Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses gastrointestinal bleeding treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for gastrointestinal bleeding treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastrointestinal bleeding treatment devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.